Asthma. Asthma
Conditions
Interventions
Intervention 1: Intervention group :Lactocare®, a Synbiotic capsule containing 1 billion CFU/Capsule of: Lactobacillus casei, Lactobacillus rhamnosus, Streptococcus thermophilus, Bifidobacterium breve
Treatment - Drugs
Placebo
Control group : Placebo capsule with same size and shape, one capsule daily for 2 months
Intervention group :Lactocare®, a Synbiotic capsule containing 1 billion CFU/Capsule of: Lactobacillus casei, Lactobacillus rhamnosus, Streptococcus thermophilus, Bifidobacterium breve, Lactobacillus
Sponsors
vice chancellor for research, Mashhad University of medical sciences.
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Children with mild persistent asthma aged between 6 to 12 years with a history of recurrence (at least two viral upper respiratory infections in past autumn) entered the study. Those with congenital abnormalities or syndromes, antibiotic or probiotic consumption during 2 weeks before study and any underlying disease were excluded
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of episodes of viral respiratory infection. Timepoint: Drring 8 weeks of study. Method of measurement: Clinical visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Salbutamol and prednisolone use - outpatient visit - Hospital Addmision. Timepoint: During 8 weeks of study. Method of measurement: Clinical visit. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed